0,968  0,002  Monophenol monooxygenase inhibitor
0,942  0,002  Phosphodiesterase 4D inhibitor
0,938  0,002  NOS2 expression inhibitor
0,916  0,002  AR expression inhibitor
0,858  0,004  Free radical scavenger
0,862  0,009  Apoptosis agonist
0,853  0,005  Antineoplastic (lung cancer)
0,835  0,002  Platelet adhesion inhibitor
0,777  0,005  Streptokinase A inhibitor
0,788  0,017  Antiinflammatory
0,771  0,005  Antiosteoporotic
0,758  0,004  NOS3 expression inhibitor
0,736  0,003  Melanin inhibitor
0,736  0,005  Bone diseases treatment
0,739  0,008  Chemopreventive
0,724  0,004  Skin whitener
0,732  0,016  Antineoplastic (breast cancer)
0,714  0,005  Antioxidant
0,711  0,003  Lipid peroxidase inhibitor
0,711  0,006  Antineoplastic (melanoma)
0,709  0,006  CTGF expression inhibitor
0,699  0,007  UGT1A9 substrate
0,705  0,013  Antileukemic
0,706  0,020  Transcription factor NF kappa B inhibitor
0,695  0,009  Antiprotozoal
0,660  0,005  Platelet antagonist
0,653  0,004  NOS3 expression enhancer
0,623  0,009  Antiparasitic
0,621  0,009  Nitric oxide antagonist
0,624  0,019  Alzheimer's disease treatment
0,610  0,009  Cardioprotectant
0,612  0,017  Antibacterial
0,610  0,017  Prostate cancer treatment
0,587  0,013  Proliferative diseases treatment
0,582  0,009  Antiprotozoal (Leishmania)
0,580  0,009  Hypoxia-inducible factor 1 alpha inhibitor
0,576  0,009  Antiprotozoal (Trypanosoma)
0,562  0,011  Antineoplastic (glioma)
0,563  0,014  Histamine release inhibitor
0,548  0,002  Estrogen receptor beta agonist
0,556  0,020  Antineoplastic (ovarian cancer)
0,555  0,020  Carcinogenic
0,536  0,009  RNA-directed DNA polymerase inhibitor
0,530  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,539  0,017  Cytostatic
0,521  0,005  Protein-tyrosine phosphatase inhibitor
0,530  0,017  Antifungal
0,519  0,010  Vasodilator
0,516  0,009  Antihelmintic
0,524  0,020  Chemoprotective
0,499  0,004  Estrogen agonist
0,502  0,007  Antineoplastic (squamous cell carcinoma)
0,505  0,011  Antihypertriglyceridemic
0,514  0,023  Antiprotozoal (Plasmodium)
0,485  0,009  Antineoplastic (carcinoma)
0,509  0,034  Antineoplastic (colorectal cancer)
0,485  0,011  Peroxidase inhibitor
0,502  0,032  Antiasthmatic
0,492  0,026  CYP2C19 inhibitor
0,477  0,011  UGT1A1 substrate
0,495  0,033  Toll-Like receptor agonist
0,485  0,024  Antineoplastic (cervical cancer)
0,476  0,018  CYP1A2 inhibitor
0,489  0,035  Antineoplastic (colon cancer)
0,459  0,008  Antihypotensive
0,493  0,048  TNF expression inhibitor
0,464  0,024  Lipoxygenase inhibitor
0,497  0,061  Caspase 9 stimulant
0,458  0,024  Mutagenic
0,439  0,005  Butyrylcholinesterase inhibitor
0,473  0,042  5 Hydroxytryptamine release inhibitor
0,450  0,021  Hypoglycemic
0,432  0,004  Electron transport complex I inhibitor
0,459  0,041  Toll-Like receptor 7 agonist
0,456  0,039  GABA C receptor rho-3 antagonist
0,445  0,032  Spasmolytic
0,433  0,020  UGT1A6 substrate
0,424  0,023  Chronic obstructive pulmonary disease treatment
0,404  0,006  Acetylcholinesterase inhibitor
0,428  0,038  Antihypercholesterolemic
0,390  0,004  Estrogen receptor alpha antagonist
0,382  0,004  Carbonic anhydrase XIII inhibitor
0,395  0,020  Antineoplastic (lymphocytic leukemia)
0,408  0,035  Cytotoxic
0,395  0,030  DNA damaging
0,382  0,017  Antimutagenic
0,370  0,010  UGT2B15 substrate
0,398  0,041  ICAM1 expression inhibitor
0,365  0,009  Phosphodiesterase inhibitor
0,412  0,059  CYP2C9 substrate
0,360  0,018  Hepatoprotectant
0,372  0,032  Antihypoxic
0,373  0,046  Antineoplastic (brain cancer)
0,348  0,026  UDP-glucuronosyltransferase substrate
0,388  0,068  Immunosuppressant
0,370  0,053  Hepatic disorders treatment
0,363  0,050  Apoptosis antagonist
0,349  0,036  Antineoplastic (glioblastoma multiforme)
0,313  0,003  Papain-like protease (SARS coronavirus) inhibitor
0,307  0,005  Phosphodiesterase IV inhibitor
0,310  0,017  Cholinergic
0,333  0,041  Antineoplastic (renal cancer)
0,323  0,031  Platelet aggregation inhibitor
0,304  0,017  Topoisomerase II inhibitor
0,286  0,011  Cystathionine beta-synthase inhibitor
0,291  0,018  Protein kinase stimulant
0,307  0,039  Antineoplastic (sarcoma)
0,351  0,082  Ulceration
0,274  0,010  Xanthine oxidase inhibitor
0,275  0,012  Antineoplastic antibiotic
0,272  0,010  Antihemorrhagic
0,265  0,005  NAD(P)H dehydrogenase (quinone) inhibitor
0,265  0,008  Estrogen antagonist
0,321  0,067  Antimycobacterial
0,273  0,025  UGT1A3 substrate
0,304  0,066  CYP1A2 substrate
0,312  0,078  Vasodilator, coronary
0,306  0,076  Caspase 3 stimulant
0,253  0,023  Interleukin 6 antagonist
0,244  0,017  SULT1A3 substrate
0,263  0,038  P-glycoprotein inhibitor
0,231  0,008  Estrogen receptor beta antagonist
0,238  0,018  5-Lipoxygenase inhibitor
0,244  0,029  Carcinogenic, group 3
0,253  0,040  UGT2B7 substrate
0,234  0,025  Genotoxic
0,228  0,021  DNA polymerase I inhibitor
0,227  0,025  Insulin secretagoues
0,284  0,083  Antineoplastic (osteosarcoma)
0,210  0,014  Topoisomerase II alpha inhibitor
0,269  0,074  GST M1-1 substrate
0,219  0,033  VEGF expression inhibitor
0,193  0,007  SULT1E1 substrate
0,256  0,080  Aldehyde oxidase inhibitor
0,211  0,034  Tubulin antagonist
0,190  0,021  SULT1A1 substrate
0,255  0,089  Radioprotector
0,179  0,013  Actinic keratosis treatment
0,174  0,010  Postmenopausal disorders treatment
0,179  0,017  Breast cancer-resistant protein inhibitor
0,313  0,151  Antidiabetic
0,313  0,151  Cyclophilin D inhibitor
0,202  0,043  Amylase inhibitor
0,238  0,080  Teratogen
0,166  0,008  Ornithine decarboxylase inhibitor
0,274  0,115  CYP3A4 substrate
0,224  0,066  Amyloid beta aggregation inhibitor
0,248  0,092  Antituberculosic
0,183  0,031  Topoisomerase I inhibitor
0,156  0,005  Phosphodiesterase II inhibitor
0,169  0,018  Heat shock protein 70 antagonist
0,210  0,061  CYP2B6 inhibitor
0,221  0,074  Interleukin antagonist
0,209  0,066  Pneumotoxic
0,148  0,006  Neuraminidase inhibitor
0,161  0,021  Dementia treatment
0,143  0,005  Phosphodiesterase 2A inhibitor
0,236  0,100  UGT2B4 substrate
0,147  0,011  Phosphodiesterase 5A inhibitor
0,179  0,044  Cyclooxygenase 1 inhibitor
0,156  0,021  Vascular dementia treatment
0,154  0,019  Alcohol dehydrogenase inhibitor
0,246  0,111  12-Lipoxygenase inhibitor
0,145  0,012  Phosphodiesterase V inhibitor
0,210  0,077  VCAM1 expression inhibitor
0,223  0,092  Antidiabetic symptomatic
0,202  0,075  Neurotrophic factor enhancer
0,165  0,038  Cholesterol synthesis inhibitor
0,130  0,003  Transcription factor RelA inhibitor
0,189  0,063  UGT1A4 substrate
0,147  0,025  Creatine kinase inhibitor
0,229  0,107  CYP2C19 substrate
0,225  0,104  Antineoplastic (bladder cancer)
0,165  0,048  Antifungal enhancer
0,213  0,096  Antineoplastic (liver cancer)
0,148  0,032  Bronchodilator
0,178  0,064  Antineoplastic (bone cancer)
0,116  0,004  Retinoic acid alpha receptor agonist
0,262  0,151  CYP2C9 inhibitor
0,170  0,059  Antiviral (Influenza A)
0,168  0,057  Cyclooxygenase inhibitor
0,201  0,091  Embryotoxic
0,155  0,050  Cyclooxygenase 2 inhibitor
0,120  0,017  HIV-1 integrase (Strand Transfer) inhibitor
0,162  0,063  Heat shock protein 90 antagonist
0,119  0,020  HIV-1 integrase (3'-Processing) inhibitor
0,142  0,044  Glutathione S-transferase substrate
0,117  0,019  Histone deacetylase stimulant
0,117  0,019  Histone deacetylase SIRT1 stimulant
0,255  0,161  15-Lipoxygenase inhibitor
0,131  0,038  Sulfotransferase substrate
0,108  0,014  Neuraminidase (influenza) inhibitor
0,199  0,106  Antineoplastic (non-small cell lung cancer)
0,208  0,117  Lipoprotein disorders treatment
0,133  0,045  Antiviral (Influenza B)
0,144  0,056  Interleukin 4 antagonist
0,171  0,084  Antirickettsial
0,175  0,088  Sensitization
0,132  0,046  Gout treatment
0,107  0,025  Na+ K+ transporting ATPase inhibitor
0,135  0,054  Antineoplastic (uterine cancer)
0,090  0,011  Carbonic anhydrase VII inhibitor
0,152  0,073  CF transmembrane conductance regulator agonist
0,088  0,010  Estrogen receptor alpha agonist
0,120  0,044  Carbonic anhydrase III inhibitor
0,192  0,117  Vascular (periferal) disease treatment
0,097  0,023  Beta tubulin antagonist
0,244  0,170  Antipruritic, allergic
0,178  0,106  Angiogenesis stimulant
0,091  0,020  Aldose reductase inhibitor
0,153  0,084  Heat shock protein 90 alpha antagonist
0,117  0,048  Beta glucuronidase inhibitor
0,118  0,055  Carcinogenic, group 2B
0,152  0,091  Cyclin-dependent kinase 3 inhibitor
0,163  0,102  Antiviral (Influenza)
0,183  0,123  Peptidyltransferase inhibitor
0,091  0,033  Lipase inhibitor
0,142  0,085  GABA C receptor rho-2 antagonist
0,091  0,033  Peroxisome proliferator-activated receptor gamma agonist
0,138  0,081  Ca2+-transporting ATPase inhibitor
0,107  0,053  Anabolic
0,124  0,072  MAO inhibitor
0,086  0,034  HIV-1 integrase inhibitor
0,153  0,102  Sedative
0,128  0,079  Bone formation stimulant
0,083  0,035  Antitreponemal
0,157  0,109  Pyruvate kinase inhibitor
0,085  0,039  SULT1A2 substrate
0,086  0,041  Keratolytic
0,168  0,124  Antineoplastic enhancer
0,118  0,074  Contraceptive female
0,186  0,143  Respiratory analeptic
0,044  0,004  Phosphodiesterase 9A inhibitor
0,137  0,098  Interferon gamma antagonist
0,150  0,111  Succinate dehydrogenase inhibitor
0,083  0,044  Antibiotic
0,069  0,032  Xanthine dehydrogenase inhibitor
0,090  0,054  Interleukin 5 antagonist
0,129  0,093  Antiprotozoal (Coccidial)
0,042  0,006  Retinoic acid receptor agonist
0,101  0,066  Urease inhibitor
0,104  0,069  DOPA decarboxylase inhibitor
0,039  0,005  Phosphodiesterase IX inhibitor
0,132  0,100  UGT2B9 substrate
0,041  0,010  Estrogen-related receptor beta antagonist
0,092  0,062  Uric acid excretion stimulant
0,186  0,158  Transcription factor STAT inhibitor
0,098  0,070  Carbonic anhydrase XV inhibitor
0,064  0,036  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,134  0,106  Mcl-1 antagonist
0,173  0,146  Nitric-oxide synthase stimulant
0,157  0,133  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,100  0,078  Multidrug resistance-associated protein 1 inhibitor
0,106  0,086  Antiseptic
0,173  0,155  Antineoplastic (pancreatic cancer)
0,056  0,038  Maillard reaction inhibitor
0,126  0,110  Adenylate cyclase stimulant
0,086  0,069  Thioredoxin inhibitor
0,028  0,014  Toll-Like receptor 4 agonist
0,143  0,128  Antimitotic
0,109  0,095  Contraceptive
0,048  0,034  Cytokine production stimulant
0,119  0,106  Farnesoid X receptor antagonist
0,089  0,078  UGT2B11 substrate
0,071  0,061  Phosphodiesterase VI inhibitor
0,101  0,092  Antiviral (Hepatitis B)
0,053  0,047  Postcoital contraceptive
0,091  0,086  UGT2B1 substrate
0,052  0,047  Aromatase inhibitor
0,032  0,028  Retinoid X receptor agonist
0,053  0,050  Pregnane X receptor antagonist
0,117  0,115  Antiviral (Herpes)

